Astex Pharmaceuticals, Inc. (US)
Martin Coronel is an experienced professional who has held various roles in quality assurance, quality control, and product quality management for several pharmaceutical companies. Martin has managed the QC functions for different companies and oversaw testing programs for various products. Coronel also has experience in implementing and overseeing systems for deviation, CAPA, and QC testing. With a Bachelor's degree in Chemistry from the University of California, Riverside, their career spans over two decades in the pharmaceutical industry.
Astex Pharmaceuticals, Inc. (US)
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies. Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc. Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.